Understanding how HIV interacts with host cell proteins to affect virus release

HIV interactions with host cell proteins in particle release

NIH-funded research Meharry Medical College · NIH-10813740

This study is looking at how HIV-1 interacts with certain proteins in our cells, especially one called tetherin that helps stop the virus from spreading, and how another protein, Vpu, works to overcome this defense; it's for anyone interested in understanding more about how HIV works and finding new ways to fight it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMeharry Medical College NIH-funded
Lab location1 site (Nashville, United States)
Project IDNIH-10813740 on NIH RePORTER

What this research studies

This research investigates the interaction between HIV-1 and host cell proteins, specifically focusing on a protein called tetherin that inhibits the release of the virus from infected cells. The study aims to explore how another protein, Vpu, neutralizes this inhibition through various mechanisms. By utilizing techniques such as live cell imaging and flow cytometry, researchers will analyze how a specific host protein, filamin A, influences the antiviral activity of tetherin and the release of HIV-1 particles. The goal is to gain insights into the molecular dynamics that could inform future therapeutic strategies against HIV.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV who are interested in understanding the mechanisms of viral replication and transmission.

Not a fit: Patients who are not infected with HIV or those who are not engaged in HIV-related research may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing HIV transmission and improving treatment options for infected individuals.

How similar studies have performed: Previous research has shown promising results in understanding viral interactions with host cell proteins, suggesting that this approach could yield valuable insights.

Where this research is happening

Nashville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.